Half-year report · HY
7634.TEDINET S100X1C2
Period2025-04-01 → 2025-09-30
Filed2025-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥15.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥864m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥881m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥918m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥925m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥916m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥925m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥622m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥623m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥627m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥634m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥25.4bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥24.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥23.6bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.9bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥5.9bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥19.5bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥18.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥18.1bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.8bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.6bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.7bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.2bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥976m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥401m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥740m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥412m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥199.22 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥469.18 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥199.7 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 75.5% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥511m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥511m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥60m |
| Care Welfare Relatedreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥582m |
| Care Welfare Relatedreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥582m |
| Care Welfare Relatedreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥60,000 |
| Home Medical Treatment Relatedreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.6bn |
| Home Medical Treatment Relatedreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.6bn |
| Home Medical Treatment Relatedreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥431m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥651m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥614m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥37m |
| Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥92m |
| Medical Gas Relatedreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.9bn |
| Medical Gas Relatedreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.9bn |
| Medical Gas Relatedreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥283m |
| Nursing Homereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥176m |
| Nursing Homereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥176m |
| Nursing Homereportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥2m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥6.9bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥6.9bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥37m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥804m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥7.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥7.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥37m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥864m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥490m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥490m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥62m |
| Care Welfare Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥581m |
| Care Welfare Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥581m |
| Care Welfare Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥20m |
| Home Medical Treatment Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.3bn |
| Home Medical Treatment Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.3bn |
| Home Medical Treatment Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥400m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥850m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥806m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥44m |
| Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥107m |
| Medical Gas Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Medical Gas Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Medical Gas Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥291m |
| Nursing Homereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥174m |
| Nursing Homereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥174m |
| Nursing Homereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥783,000 |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥6.8bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥6.8bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥44m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥819m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥7.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥7.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥44m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥881m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 500
| Item | Context | Value | Unit |
|---|---|---|---|
| Extraordinary income | Prior1InterimDuration | 943000 | JPY |
| Extraordinary income | InterimDuration | － | JPY |
| Loss on retirement of noncurrent assets el | Prior1InterimDuration | 892000 | JPY |
| Loss on retirement of noncurrent assets el | InterimDuration | 1600000 | JPY |
| Extraordinary loss | Prior1InterimDuration | 892000 | JPY |
| Extraordinary loss | InterimDuration | 1600000 | JPY |
| Income before income taxes | Prior1InterimDuration | 925030000 | JPY |
| Income before income taxes | InterimDuration | 915994000 | JPY |
| Income taxes | Prior1InterimDuration | 291176000 | JPY |
| Income taxes | InterimDuration | 289457000 | JPY |
| Profit loss | Prior1InterimDuration | 633853000 | JPY |
| Profit loss | InterimDuration | 626536000 | JPY |
| Profit loss attributable to non controlling interests | Prior1InterimDuration | 10955000 | JPY |
| Profit loss attributable to non controlling interests | InterimDuration | 4319000 | JPY |
| Profit loss attributable to owners of parent | Prior1InterimDuration | 622897000 | JPY |
| Profit loss attributable to owners of parent | InterimDuration | 622217000 | JPY |
| Profit loss | Prior1InterimDuration | 633853000 | JPY |
| Profit loss | InterimDuration | 626536000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1InterimDuration | 168611000 | JPY |
| Valuation difference on available for sale securities net of tax oci | InterimDuration | 238545000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1InterimDuration | -10798000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | InterimDuration | -4995000 | JPY |
| Other comprehensive income | Prior1InterimDuration | 157812000 | JPY |
| Other comprehensive income | InterimDuration | 233549000 | JPY |
| Comprehensive income | Prior1InterimDuration | 791666000 | JPY |
| Comprehensive income | InterimDuration | 860086000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1InterimDuration | 785553000 | JPY |
| Comprehensive income attributable to owners of the parent | InterimDuration | 848162000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1InterimDuration | 6113000 | JPY |
| Comprehensive income attributable to non controlling interests | InterimDuration | 11924000 | JPY |
| Income before income taxes | Prior1InterimDuration | 925030000 | JPY |
| Income before income taxes | InterimDuration | 915994000 | JPY |
| Depreciation and amortization ope cf | Prior1InterimDuration | 407024000 | JPY |
| Depreciation and amortization ope cf | InterimDuration | 451211000 | JPY |
| Amortization of goodwill ope cf | Prior1InterimDuration | 2069000 | JPY |
| Amortization of goodwill ope cf | InterimDuration | － | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | Prior1InterimDuration | 64560000 | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | InterimDuration | 90030000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1InterimDuration | -2612000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | InterimDuration | -396000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1InterimDuration | -39900000 | JPY |
| Increase decrease in provision for bonuses ope cf | InterimDuration | -34000000 | JPY |
| Interest and dividends income ope cf | Prior1InterimDuration | -35843000 | JPY |
| Interest and dividends income ope cf | InterimDuration | -55940000 | JPY |
| Interest expenses ope cf | Prior1InterimDuration | 1975000 | JPY |
| Interest expenses ope cf | InterimDuration | 6708000 | JPY |
| Loss gain on sales and retirement of property plant and equipment ope cf | Prior1InterimDuration | -801000 | JPY |
| Loss gain on sales and retirement of property plant and equipment ope cf | InterimDuration | 1600000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1InterimDuration | 253805000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | InterimDuration | 396038000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |